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Preface: Law of Gravity
 1686: Sir Isaac Newton first published: 
mutual attraction of bodies in nature
 1798: First test of Newton's theory of 
gravitation between masses in the 
laboratory - Cavendish experiment
 1915: Einstein’s general theory of 
relativity: gravity as a distortion of 




 I have no relevant financial relationships with any 
commercial interests to disclose.
 The content of this presentation has been peer reviewed 
for fair balance and evidence based medicine.
Advanced Evidence Based Medicine = Creative Expertise
The Novice Stage: Learns the basic rules and applies them 
mechanically with no attention to context.
Second and Third Stages: Increasing depth of knowledge 
and sensitivity to context when applying rules.
Fourth and Fifth Stages: Rule following gives way to 
expert judgments - characterized by rapid, intuitive 
reasoning informed by imagination, common sense, and 
judiciously selected research evidence.
Advanced evidence based medicine is not rule following.
There are five levels of learning:
Advanced Evidence Based Medicine = Creative Expertise 
Creative People [Creative Brains] have an “openness to new experience that permits 
them to observe things than others cannot… [this] openness is accompanied by a 
tolerance for ambiguity. Creative people do not crave the absolutism of a black and 
white world; they are quite comfortable with shades of gray. In fact, they enjoy living 
in a world with unanswered questions and blurry boundaries.”
Nancy Andreasen, The Creative Brain: The Science of Genius, p. 31
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Introduction to HBOT: Physics
 Henry’s Law of Gas Solubility: 
The solubility of a gas in a 
liquid is directly proportional 
to the partial pressure of the 
gas above the liquid.
 Increasing the atmospheric 
pressure increases the 
amount of gas that is 
dissolved into a fluid. 
 Oxygen → Blood Plasma
A B
Introduction to HBOT: Physiology




 Clinical Hyperbaric Pressures
 7 – 22 psi
 10 – 15 normal amount of oxygen
 Bypasses body’s normal system of transporting oxygen 
Introduction to HBOT: 
Mechanism of Action
 Limits ischemic damage, cell death, 
inflammation
 Promotes collagen synthesis (fibroblast 
stimulation)
 Decreases lactate production and tissue 
acidosis
 Aids in oxygen dependent killing of 
bacteria – WBC
 Limits leukocyte adhesion and 
degranulation
 Decreases tissue edema
HBOT: Mechanisms for 
Addressing Chronic Pain 
HBOT: Mechanisms for 
Addressing Chronic Pain 
 Decreases inflammation, 
reduces hypoxia, and 
improves microcirculation
 For neuropathic pain, 
analgesic and antinociceptive 
effects are due to cellular 
modulation 
 Autophagy in the 
mitochondria of microglia 
(mitophagy) 
(Han et al., 2017)
HBOT: Mechanisms for Addressing Chronic Pain
 Mitochondria are the primary source of ROS
 ROS can:
 Induce mutations in mtDNA causing protein 
deficiencies
 Restrict ability to self-repair, leaving cells 
more vulnerable to ROS attack
 Damage mitochondrial proteins and lipids 
by inducing oxidative stress
(Nie et al., 2015; Koirala et al., 2013; Lupfer et al., 2013)
HBOT: Mechanisms for Pain
Latent mitochondria are like campfires left burning all night
 HBOT modulates cellular autophagy 
(mitochondria of microglia) and 
directly reduces pain
 Appropriate clearance of 
mitochondria is important for 
maintaining homeostasis in cells
HBOT: Addressing Chronic Pain 
with Mitophagy
HBOT: Addressing Chronic Pain with Mitophagy
Mitophagy study with 80 rats (Han et al., 2017)
 20 rats were given a CCI (chronic 
constriction injury); 20 rats got 
CCI+ HBOT
 20 rats were sham CCI and 20 rats 
were controls
 All 80 rats were given CSI (a 
mitophagy) before testing
 MMP was used to measure 
mitophagy (lower MMP observed 
with more mitophagy)
 HBOT improved mitochondrial 
permeability via transitive 
pores on the mitochondrial 
membrane
 More permeability results in 
more mitophagy (see as 
lowered MMP) which reduces 
ROS calming neuro-
inflammation and pain
Control & Sham – minimal to no mitophagy (no change in MMP)
MMP: Mitochondrial membrane potential 
CCI: Chronic constriction injury
HBOT: Addressing Chronic Pain with Mitophagy
Mitophagy study with 80 rats (Han et al., 2017)
Mitophagy is putting the mitochondrial fires out by involuting the ashes and soil upon 
the remaining embers. Without mitophagy, wildfires (of pain) get out of control.
July 4th, 2018 Basalt, CO (Courtesy of Pete McBride)
Fun Fact #1: What else encourages cellular autophagy 
(including neuronal autophagy)?
Intermittent Fasting!
Dr. Yoshinori Ohsumi Wins Nobel Prize for this discovery)
https://www.garmaonhealth.com/intermittent-fasting-cellular-autophagy/
HBOT: Other Mechanisms for Addressing Chronic Pain
(Zhao, B., Pan, Y., Xu, H., & Song, X., 2017)
 Suppresses pro-inflammatory cytokines, 
such as IL-1, IL-6 and TNF-alpha and 
simultaneous releases anti-cytokines
 Suppresses astrocyte activation and 
inflammatory responses (stopping 
gliosis) by:
 Increasing TNF-α
 Decreasing Kindlin-1 and Wnt-10a in 
the dorsal root ganglia (DRG), spinal 
cord, and hippocampus of rats
HBOT: Mechanisms 
for Chronic Pain: 
Case Study
 40 year old spinal cord injury 
(C4 burst fx from mtn biking 
accident) paraplegic patient 
with chronic spasticity and 
pain in lower extremities
 Reports almost immediate 
reduction in neuroplasticity, 
inflammation, and pain 
when treated in a HBOT 
chamber at 2.4 ATA
HBOT: Upregulates Pluripotent Adult Stem Cells 
(aka VSELs - very small embryonic-like stem cells) 
in the blood
“[Hyperbaric oxygen 
therapy] is the safest way 
clinically to increase stem 
cell circulation, far safer 
than any of the 
pharmaceutical options.”
Stephen Thom, MD, Ph.D. (2005)
HBOT: Upregulates 
Pluripotent Stem Cells 
in the Blood
Mean CD34+ population in 
blood of humans before 
and after HBO2 treatments
Data are the fraction of 
CD34+ stem cells within the 
gated population using 
blood obtained from 26 
patients before and after 
their 1st, 10th, and 20th 
HBO2 treatment (Thom, et al., 2006) 
HBOT: Upregulates 
Pluripotent Stem Cells 
in the Blood 
 2 hours = 3x amount of stem 
cells circulating stem cells in 
your blood
 20 sessions = 800% more 
stem cells circulating stem 
cells in your blood
 Released through a nitric 
oxide process stimulated by 
HBOT
 Repairing tissue damage 
with endogenous VSELs 
and growth factors is the 
body’s primary way to 
stop the cause pain
 VSELs can be also 
harvested by blood draw, 
isolated, and activated 
HBOT: Upregulates 
Pluripotent Stem Cells 
(VSELs) in the Blood 
Pluripotent (VSELs) vs. Multipotent (Mesenchymal-MSCs)
 Many stem cell clinics are focused 
on the use of mesenchymal stem 
cells (MSCs)
 MSCs are derived from bone 
marrow, umbilical, or fat 
 MSCs have merit for homologous 
use (bone marrow to bone marrow 
or fat to fat transplantation)
 MSCs do not actually transform, in 
vivo, to new tissues
Pluripotent (VSELs) Multipotent (Mesenchymal)
Recently discovered in peripheral 
blood
From bone marrow, fat, and cord 
blood
Also known as very small 
embryonic-like stem cells (VSELs)
Mesenchymal stem cells (MSCs)
Does not have a specialized 
trajectory of development
On a development trajectory
Give rise to all the cell types Specialization potential limited to 
one or more cell lines
Lineage uncommitted Lineage committed
Long lifespan Short-lived
Not restricted by FDA Increased FDA restriction for non-
homologous tissue use




• Osteoarthritis / osteoporosis
• Alzheimer’s disease
• Regenerative applications:
• Traumatic brain injury
• Joint / ligament repair
• Anti-aging
• Post cancer treatment
• Fertility
Pluripotent (VSELs)
• Tissue Replacement (Homologous 
Only):
• Bone marrow transplant
• Breast, lips, cheeks, eyes, buttocks 
• Systemic inflammatory conditions:
• Autoimmune disorders
• Acute renal failure
• Myocardial infarction





• These cells do not develop into new cartilage cells – they 
only provide growth factors
• Therapeutic effects are short-lived
• “Recent studies have suggested that less than 1% of 
systemically administered MSCs persist for longer than a 
week following injection” (Parekkadan & Milwid, 2010, 
pg 2).
Mesenchymal Stem Cells (Multipotent): 
Clinical Indications
• Harvesting of bone marrow and fat can be unpleasant
• Repeat harvesting is limited
• Immunomodulatory effects can predispose the patients to 
more infections or even cancer
• Reduces inflammation for 6 months – 2 years but have 
limited regenerative benefits
Mesenchymal Stem Cells (Multipotent): 
Dangers
Lineage uncommitted pluripotent stem cells can 
produce all types of cells in the germ layer
Pluripotent Stem Cells (VSELs)
Pluripotent Stem Cells (VSELs)
Displaced (5mm) C-7 proximal spinal 
fracture failed to heal 9 months post 
trauma
Pre-Treatment Post-Treatment
4 months post-treatment of peripheral 






Cells for Sports 
Injuries and Arthritis
HBOT for Sports Injuries
 Reduces swelling 
 Blunts the inflammatory process
 Improves range of motion earlier/ PT
 Increases and enhances tissue growth
 Fibroblast and osteoblast 
proliferation
 Improves bone regeneration-faster 
and stronger fracture repair
Case Study
 Injured on January 5th 2009 
 Shearing fracture, surgically 
repaired
 High risk for Non-Union
 Started HBO January 7th 2009 
 30 tx over 6 week period
 Cleared to ski March 3rd 2009

Professional Sports - Twelve NFL teams own HBOT chambers
 “Ward is using hyperbaric chamber to accelerate recovery” -USA Today
 “Football superstar Terrell Owens used hyperbaric oxygen therapy to hasten his 
recovery from an ankle injury so that he could play in the Super Bowl.” -Fox 
Sports
 Cincinnati Bengals defensive tackle Bryan Robinson says “hyperbaric oxygen 
therapy was the catalyst in getting a nagging ankle injury to heal.” -Cincinnati 
Inquirer
 “Linebacker Kevin Burnett credits hyperbaric oxygen therapy for helping him get 
back onto the playing field quickly after surgery to repair cartilage damage in 




 Increases tissue oxygenation
 Generates new capillary 
networks
 Restores blood supply
 Increases stem cells in the 
blood
Traumatic Brain Injury: Pre Treatment
 10 treatments in a HBOT 
medical grade facility 
 1.5 to 1.75 ATA
 Or at least 3-4 weeks in a 
home HBOT chamber 
 Stem cell enhancing 
supplements are taken 2 











Intranasal (IN) PRP and insulin
Day 1:
IV and IN NAD+ 
IV and IN pluripotent stem cells 
(VESLs) from the blood
HBOT
Day 2:
Protocol For Traumatic Brain Injury:
Post Treatment
 Medical grade HBOT: 10-30x (at 1.5 to 1.75 ATA) over next month
 Repeat 20 treatments at 3 months; repeat 20 treatments at 6 
months 
 Alternative: Home low pressure O2 chambers (at 1.3 ATA) 5-7 
days/week for 1.25 hours for 3 months 
 Then at least 4 days/week for 9 months 
 Home administration of intranasal insulin 10 days or more
 PT, cranial osteopathy, functional medicine (including hormone 
management), and other therapeutic modalities (vision therapy, 
neurofeedback, LLLT, ketogenic diet)
“In June 2017, I went in for my second
intranasal stem cell procedure and by
August I felt well enough that I started
saying yes again to facilitating events and
speaking gigs. I also experienced relief
from anxiety. With the stem cell
procedures, the results were never
immediate but 8-12 weeks post procedure I
experienced a noticeable jump in my
healing. Even though, I’m still not 100%
back to what I was, TBI Therapy has turned
me into a TBI THRIVER, not just a survivor.
I’m happy. I enjoy life again, can travel
and am doing work in the world that’s
more aligned with myself than ever.”
“I am now officially 5 weeks post
intranasal/IV stem cell and PRP
treatment and the results for me have
been are nothing short of MIRACULOUS!
Trust me when I say that losing who you
are from a traumatic brain injury is
absolutely devastating! Over the years I
learned how to coexist with my brain
injury and the issues that came along
with it but only a select few close to me
could tell I was still struggling at times.
Until now... Popeye may have his
spinach but I have stem cells and
PRP! Yes, my brain is strong!”
Arthritis Case Report
 80 year old with tricompartmental arthritis x 10 years, 
confirmed by xray, worse in R knee
 Treated with VSELs in Bilat Knee joints, menisci, and associated 
ligaments on 2/9/2018
 Reports on 4/13/2018 that her left knee does not hurt
 Reports improvements in walking with less R knee pain on 
6/7/2018. Patient provided booster PRP injection into R knee 
joint and IT band at 6/7/2018
 "The only consistent symptom I have is that it is always 
uncomfortable when I stand up from a sitting position and 
when I first get up in the morning. Usually just a few steps and 
the discomfort is gone."
HBOT: 
Adjunctive to IV 
Therapies for 
Chronic Infection
HBOT: Adjunctive to IV Therapies for Chronic Infection
 HBOT alone: Helps Osteomyelitis, 
subcutaneous infections, systemic 
infections such as herpes, EBV, etc. 
 HBOT (2.0+ ATA) + IV ascorbate (in excess 
of 50g), has an even greater effect on 
many chronic infectious conditions 
(including chronic viral (like EBV), 
immunosuppression, and post-Lyme 
syndrome)
 With catalytic metal ions, ascorbate has pro-oxidant 
effects
 Ascorbate reduces ferric (Fe3+) to ferrous (Fe2+) 
iron. Increase Ascorbate = Increase Fe2+
 AscH- + Fe3+ → Asc•- + Fe2+
 Fe2+ can readily react with O2, reducing it to 
superoxide radical. Increase O2 = Increase O∙−2
 Fe2++O2→Fe3++O∙−2
 The superoxide radical dismutes to H2O2 and O2
 O∙−2+O∙−2+2H+→H2O2+O2 Increased H2O2
HBOT: Adjunctive to IV Therapies for Chronic Infection:
Driving the Fenton Reaction with Ascorbate
 In a classic Fenton reaction, Fe2+ reacts with 
H2O2 to generate Fe3+ and the very oxidizing 
hydroxyl radical.
 Fe2+ + H2O2 → Fe3+ + OH• + OH-
 This OH radical is incredibly deadly to viruses, 
bacteria, spirochetes, other pathogens, and, 
reportedly cancer cells
 Healthy cells are protected from peroxide radicals 
by the enzyme catalyze
HBOT: Adjunctive to IV Therapies for Chronic Infection:
Driving the Fenton Reaction with Ascorbate
 Stimulating this reaction can create interferon like 
side effects in the patients
 Patients report areas of prior injuries or inflammation 
can get flared up, achy, or significantly painful
 Most patients report abdominal/diaphragmatic pain 
that resolves within 2-20 minutes after getting out of 
the chamber
 Fun Correlation: This is further evidence that the 
increased presence of ROS leads to nociceptive pain
HBOT: Adjunctive to IV Therapies for Chronic Infection:
Driving the Fenton Reaction with Ascorbate
 Patients may need more bioavaibie iron: the typical 
range for the iron dose is 1 part of Fe per 5-25 parts 
of H2O2
 pH adjustment to 3-5 : if the pH is too high the iron 
precipitate in Fe(OH)3 and will decompose the H2O2 
to oxygen. 
 Basically, the optimal pH occurs between 3 and 6
 Do not give the patient a neutralized bag of 
ascorbate—pH must be at least than 5-6 in the bag
HBOT: Adjunctive to IV Therapies for Chronic Infection:
Driving the Fenton Reaction with Ascorbate
Case Report: Lyme Disease
History
 60 yo female reported diagnosis of Lyme disease with HHV6, EBV, M.Pn, Babesia, Erlichia
 R ocular pain, R vision loss, extreme fatigue, diagnosed with 9 bands/10 bands for 
Borellia - Treated with Doxycline and unspecified antibiotic 
 Worsened with intractable R eye pain, vision loss, extreme sensitivity to light, tingling in 
her R UE and LE and wheelchair bound after 6 months
 Received IV Rocephin and other antibiotics including Doxycline and Azithromycin, and 
nutritional IV therapies including EDTA, turmeric, ascorbate, alpha lipoic acid, 
glutathione, and amino acids
 Walking again but still suffered extreme R eye pain, vision loss, migraine headache pain, 
elevated liver function tests, elevated lipase, chronic fatigue, and skin rash
 Reported being unable to work and bed ridden with fatigue
Case Report: Lyme Disease
Treatment
 IV sodium ascorbate 
 Up to 95 g non-corn based ascorbate with minerals (Ca,Mg, K) 3 days/week
 Hyperbaric oxygen therapy 
 Up to 2.4 ATA (1 hour after receiving IV ascorbate) 3 days/week
 After 20 weeks:
 Improvement in condition of pancreatitis with a resolution of her lipase value and 
liver function tests
 Less fatigue and improved energy to think more clearly, improved ability to stay up 
later and take walks during the afternoon
 Improvement in her eye pain and ability to use the computer for more than 5 minutes 
at a time 
 Referred to a holistic ophthalmologist for continued care
Case Report: Lyme Disease
 Chronic Lyme disease is often 
accompanied by toxins and 
viruses that cannot be 
eliminated by simply using 
antibiotic therapy. 
Without HBOT and Vitamin C 
treatment, this patient would 
not have gotten better.
Case Report: Mold Toxins
 34 yo male with L temporal glioma and seizure 
condition – likely secondary to mold toxins in home
 11/2017 Diagnosed with glioma - surgically removed
 12/2017 Tumor just as large as before removal
 3/2018 Moved out of condo and began IV Ascorbate 
and HBOT
 4/2018-6/2018 Chemo therapy and radiation therapy, 
continued IV ascorbate 1-2x/week at 60 g (stopped 
HBOT due to seizure)
 6/26/2018 Complete resolution - no tumor at all 
seen on MRI, no seizures
 Played intense soccer game with no issues
Organ data
Ascorbic Acid Inhibits VM-M3 Cells In Vitro
Organ data
Anti-cancer effect of ascorbic acid in vitro
Experimental Design
VM-M3 Cell Death 
Effect of NAC on AA-mediated Cytotoxicity
Acknowledgements
Figure 2. AA may decrease VM-M3 cell proliferation in vitro. 0.05, 0.1, 0.3, and 0.5 mM AA 
exhibited a trend of decreased proliferation compared to the control and 0.01 mM AA. This 
experiment will be repeated to test for statistical significance. 
AA-induced cell death:
• Highly metastatic cells derived from a spontaneous brain 
tumor in VM/Dk inbred mouse
• Cytotoxicity/ viability was measured in VM-M3 cells with 
fluorescence microscopy, using dyes calcein AM and EthD-1 to 
identify live and dead cells, respectively- cells labeled with both 
calcein AM and Ethd-1 may indicate early stages of necrosis and 
were counted as dead (Ethd-1 binds with nucleic acids inside the 
cell, indicating a loss of membrane integrity)
• Cells were treated with pharmacological concentrations of AA 
ranging from 0.001 mM to 5 mM
Conclusions/ Future Directions
Potential Synergy of AA and HBOT
Additional Preliminary Findings
• High-dose AA shows an anticancer effect in vitro and exhibits cytotoxicity through
an oxidative stress mechanism
• HBOT may enhance this therapeutic effect
• These findings indicate that high-dose AA should be further investigated as an
adjuvant to the current standard of care
• Further studies include:
• Evaluating the effect of HBOT on the proliferation of AA-treated VM-M3 cells
• Evaluating role of hydrogen peroxide (H2O2) in AA-induced cytotoxicity with
treatment of catalase- an enzyme that breaks down H2O2 to water and oxygen
AA’s effects on 
proliferation:
• Cancer is the second leading cause of death in the U.S.
• Projected to take 595,690 lives in 2016 and cost the nation over $125 billion
• To effectively reduce these detrimental losses, non-toxic, low-cost therapies should 
be further examined to supplement the standard of care
• Anti-carcinogenic and minimally toxic therapy under investigation: high-dose 
ascorbic acid (AA)
• AA can function as a pro-oxidant at pharmacological levels (achieved I.V. or I.P.) 
• Delivers hydrogen peroxide (H2O2) to tumorous tissue upon oxidation and 
initiates cell death
• High-dose AA has elicited significant anticancer effects in animal models and small-
scale human reports at concentrations nontoxic to healthy cells
• We aim to examine the anticancer effect of AA in vitro and to mechanistically 
evaluate AA-induced oxidative stress, as well as investigate AA’s synergy with 
another non-toxic metabolic therapy: Hyperbaric Oxygen Therapy (HBOT)
I. Determine the effect of AA on viability and proliferation in vitro
II. Evaluate the mechanism of AA-induced cytotoxicity: N-Acetyl cysteine (NAC) is 
an antioxidant precursor to glutathione, an antioxidant that is highly abundant in 
the body and scavenges free radicals. If treatment with NAC attenuates the 
therapeutic effect of AA, this finding would support the hypothesis that 
oxidative stress mediates AA-induced cytotoxicity
III. Investigate if synergy exists between HBOT and AA: HBOT is a medical treatment 
used to heal wounds, radiation injury, decompression sickness, and other health 
ailments by delivering 100% oxygen at elevated barometric pressure; since HBOT 
enhances free radical production and oxidative stress, we hypothesize that it 
will synergize with AA and further decrease VM-M3 cell viability
• We anticipate that this approach will yield significant insight into and further 
investigate the hypothesis that AA is an effective adjuvant to the standard of care
A
VM-M3 Cell Proliferation
Figure 3.   Antioxidant NAC attenuates the effect of AA in vitro. 24 hour treatment with 5mM NAC 
mitigated AA-induced cytotoxicity (One-way ANOVA, p<0.0001). 0.5mM AA was also considered 
significant when compared to control and control + 5mM NAC (p<0.0001).
Figure 4.   HBOT and AA synergize in vitro. 24 hour treatment with HBOT and 0.3 mM AA 
significantly increased cytotoxicity compared to all other treatments  (One-way ANOVA, p<0.001). 
0.3mM AA was also considered significant when compared to control (p=0.002) and control + HBOT 
(p=0.015). The addition of HBOT did not affect control and 0.1 mM AA. 
B
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Figure 1. AA mediates VM-M3 cell death in a concentration-dependent manner. (A,B) 24 
hour treatment with 0.5, 2, and 5 mM AA significantly induced cytotoxicity compared to 
control and all other tested concentrations (One-way ANOVA, p<0.001).

























































Treatment with antioxidant NAC and AA:
AA and HBOT Combination:
• Standard trypan blue hemocytometry was used to measure proliferation
• Cells were treated with varying concentrations of AA, and were counted after 
growth periods of 24, 48, 72, and 96 hours
• Cells were treated with a cytotoxic concentration of AA (0.5 
mM), in the presence or absence of 5 mM NAC
• VM-M3 cells were treated with one session of HBOT (100% O2, 60 mins, 2.5 ATA)
• AA concentrations below 0.5 mM were used since > 0.5 mM AA already induces 
high % cell death
VM-M3 Cells:
Facilities use at Laboratory of Metabolic Medicine (Director, Dr. Dominic D’Agostino)
and Hyperbaric Biomedical Research Laboratory (Director, Dr. Jay B. Dean). Work
supported by: USF Foundation (501c3); Metabolic Therapy and Cancer Research




























































1) Physician who treat patients with chronic orthopedic or neuropathic pain or 
inflammation should consider the primary use of HBOT to alleviate that pain or as an 
adjunctive therapy in combination with other modalities to effectively address the source 
of the pain.
2) Stem cell mobilization by HBOT is perhaps one of the most effective uses of the HBOT in 
regenerative medicine. These stem cells can be extracted easily from the blood and 
injected locally to address a variety of pain conditions.
3) Used in combination with high dose ascorbate, HBOT can be one of the most effective 
ways to eliminate pathogens in patients suffering from acute, chronic, localized, or 
systemic infections.
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